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Abstract: Many, if not all, environmental pollutants/chemicals and infectious agents 
increase intracellular levels of reactive oxygen species (ROS) at the site of exposure. ROS 
not only function as intracellular signaling entities, but also induce damage to cellular 
molecules including DNA. Among the several dozen ROS-induced DNA base lesions 
generated in the genome, 8-oxo-7,8-dihydroguanine (8-oxoG) is one of the most abundant 
because of guanine’s lowest redox potential among DNA bases. In mammalian cells,  
8-oxoG is repaired by the 8-oxoguanine DNA glycosylase-1 (OGG1)-initiated DNA base 
excision repair pathway (OGG1–BER). Accumulation of 8-oxoG in DNA has traditionally 
been associated with mutagenesis, as well as various human diseases and aging processes, 
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while the free 8-oxoG base in body fluids is one of the best biomarkers of ongoing 
pathophysiological processes. In this review, we discuss the biological significance of  
the 8-oxoG base and particularly the role of OGG1–BER in the activation of small 
GTPases and changes in gene expression, including those that regulate pro-inflammatory 
chemokines/cytokines and cause inflammation. 
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1. Introduction 
The etiology of inflammatory lung diseases is diverse, and often linked to environmental pollutants 
(generated by natural processes and industrial activities such as heating, oil, chemical processing, 
vehicle operations, cooking, and tobacco smoking) and exposure to biological agents (pollens, viruses, 
fungi and/or bacteria). When inhaled, such pollutants primarily impact the surface of the airway 
(airway lining fluid and epithelia), and when in excess, their interactions with the airway epithelium 
and resident immune cells usually result in the release of pre-synthesized inflammatory mediators,  
or gene expression, including that of pro-inflammatory genes, and cause acute inflammation and/or 
lead to both flare-up and worsening of established diseases (reviewed in [1–3]). 
Most, if not all, environmental agents elicit the generation of reactive oxygen species (ROS), either 
directly, indirectly or both, which is among the first cellular responses. ROS operate as intracellular 
signaling molecules, a function that is commonly documented but whose mechanism is not fully 
understood [4]. Due to reactivity, ROS modify proteins, lipids, and DNA. In the DNA, one of the most 
common oxidation products is 8-oxo-7,8-dihydroguanine (8-oxoG) [5]. Oxidatively damaged DNA  
bases such as 8-oxoG are preferentially repaired by the base excision repair (BER) pathway [6,7]. While 
oxidative stress causes increased levels of all types of oxidatively modified DNA bases, accumulation  
of 8-oxoG in the DNA has been specifically linked to various inflammatory disease processes [7,8]. 
In this review, we discuss the significance/role of genomic 8-oxoG and the 8-oxoguanine DNA 
glycosylase-1 (OGG1)-generated 8-oxoG base in lung inflammatory processes and inflammation-associated 
pathologies. We also provide data to support the novel concept of a role for OGG1-generated  
DNA repair intermediate(s) and repair products in the activation of cellular signaling controlling  
pro-inflammatory gene expression, and its possible link to acute and chronic inflammation that may  
be important in lung diseases. 
2. Results and Discussion 
2.1. Defense against the Accumulation of 8-oxo-7,8-Dihydroguanine (8-oxoG) in the Genome 
The primary ROS generated by biological processes are the superoxide anion (O2−) and the non-radical 
oxidant hydrogen peroxide (H2O2). These reactive species are promptly detoxified, but when in excess, 
are converted into a hydroxyl radical (·OH), the most reactive oxygen-centered radical [9]. In DNA  
or RNA, ROS including ·OH primarily damages guanine because it has the lowest ionization potential 
among nucleic acid bases [10–12]. Mechanistic studies show that when, e.g., ·OH interacts with 
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guanine, it results in a reducing neutral radical that reacts with molecular oxygen (O2) and, via electron 
transfer, forms 8-oxoG [13–15]. Guanine is preferentially oxidized when it is located at the 5'-end  
of a series of guanine, often found in promoter/enhancer sequences of various genes and telomeres [16]. 
Preferential guanine oxidation has been attributed to the migrating radical cation of the guanine,  
with termination by trapping and forming the final product [10,16]. It is estimated that up to 100,000 
8-oxoG lesions could be formed in DNA per cell daily (reviewed in [5]). 
To prevent 8-oxoG accumulation and its mutagenic effects, mammalian cells express DNA  
repair proteins that are analogous to the Escherichia coli proteins MutM (formamidopyrimidine  
DNA glycosylase, also known as Fpg), Nei (endonuclease VIII-like DNA glycosylase), and MutT  
(8-oxo-7,8-dihydrodeoxyguanosine triphosphate GTPase) [17]. OGG1 is an eukaryotic functional homolog 
for MutM that excises 8-oxoG and its open-ringed form 2,6-diamino-4-hydroxy-5-formamidopyrimidine 
(FapyG) from the 8-oxoG/FapyG:C mis-pairing [18]. OGG1 has targeting signals for both 
mitochondrial import (amino acid residues 9–26) and nuclear localization (amino acids 335–342) [19]. 
OGG1 is a bifunctional DNA glycosylase with an associated apurinic/apyrimidinic (AP) lyase activity 
that cleaves DNA at abasic sites via a β-elimination mechanism (reviewed in [17,20]). 
Figure 1. Graphical illustration of 8-oxoguanine DNA glycosylase-1 (OGG1)-initiated genome 
damage repair. OGG1 is a DNA glycosylase/AP lyase that first hydrolyses the N-glycosyl  
bond releasing 8-oxoG as a free base and subsequently cleaves the sugar-phosphate backbone 
directly, generating an apurinic/apyrimidinic (AP)-site(s). Apurinic/apyrimidinic endonuclease 1 
(APE1) processes the single-strand gap by removing the 3'-phospho-α,β-unsaturated 
aldehyde residue to form a 3'-OH end. DNA polymerase β inserts guanine, and the nicks 
are ligated by ligase II/XRCC1. AP site, apurinic/apyrimidinic site; APE1, apurinic/apyrimidinic 
endonuclease1; DNA Polβ, DNA polymerase β; XRCC1, X-ray cross-complementing protein 1. 
 
OGG1-initiated DNA base excision repair pathway (OGG1–BER) is a multistep process, which 
includes lesion recognition, changes in DNA structure, insertion of the 8-oxoG-containing DNA double 
helix into the base-binding pocket (active site) of OGG1, and base excision and strand cleavage [17,20,21]. 
The catalytic site of OGG1 is localized to Lys-249 and Asp-268, and both are in the conserved  
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helix–hairpin–helix (HhH) region of the molecule. HhH is adjacent to a Gly/Pro-rich loop and a conserved 
aspartic acid motif, which is essential for the glycosylase as well as DNA-binding activity. During repair 
processes, 8-oxoG is flipped into the OGG1 substrate-binding pocket, and then is inserted between  
the Phe-319 and Cys-253 and the de-protonated thiolate anion at Cys-253 that stabilizes interactions 
between the positively charged Lys-249 and nucleobase. The flipped out 8-oxoG base is excised  
via cleavage of its N-glycosidic bond, and 8-oxoG is released from DNA as a free base [21,22]. 
After 8-oxoG base removal, OGG1, via its AP-lyase activity, cleaves the DNA phosphate backbone 
at the abasic site by formation of 3'-phospho-α,β-unsaturated aldehyde (3'dRP) and 5'-phosphate 
termini (called apurinic/apyrimidinic (AP)-site). The 3'-dRP terminus produced by the β-elimination 
reaction cannot serve as a primer for repair synthesis by DNA polymerases, so it must be removed  
by a 3'-phosphodiesterase activity of the apurinic/apyrimidinic endonuclease 1 (APE1), generating  
a 1-nucleotide gap [17,20,22]. DNA polymerases, primarily the DNA polymerase β, then incorporate 
guanine at the gapped site, and the resulting nicks are subsequently sealed by a DNA ligase to complete 
the repair process (Figure 1). 
2.2. 8-oxoG Is a Biomarker of Oxidative Stress 
2.2.1. 8-oxoG Is a Biomarker of Environmental Lung Exposures 
Compelling evidence has established that guanine is the main target for ROS in DNA, with 8-oxoG 
being the most frequent base lesion [13–15]. Therefore, 8-oxoG is considered and routinely used  
as a biomarker of oxidative damage to DNA [5]. The level of genomic 8-oxoG correlates well with the dose 
and length of exposure, chemical composition, and physical nature of the inhaled agents/oxidants [23–28]. 
For examples, intrahelical levels of 8-oxoG were significantly increased in lung epithelial resident 
macrophages, peripheral blood monocytes, and exogenomic 8-oxoG/7,8-dihydro-8-oxo-2'-deoxyguanosine 
(8-oxodG) levels in body fluids (e.g., serum, urine, sputum, bronchoalveolar lavage (BALF)) upon 
exposure to environmental pollutants (e.g., various gases: ozone, NO2), metals (e.g., lead, cadmium), 
smoke of various origins, particulate matter (fine, ultrafine particles), chemicals (bisphenol, arsenic,  
and so on), radiation and others) [26,27,29–35]. The estimated fold changes in 8-oxoG levels in DNA and 
its concentration in body fluids were significantly increased, but the extent of these changes varied, 
primarily due to differences in the sensitivity of the technology used (e.g., high-performance liquid 
chromatography, reversed-phase liquid chromatography with electrospray tandem mass spectrometry 
detection and isotope dilution method, Comet assay, or ELISA) [23–35]. Together, these findings  
provide strong evidence that environmental lung exposures induce oxidative damage to DNA in the form 
of increased levels of oxidative bases (and strand lesions), primarily 8-oxoG. 
2.2.2. Oxidatively Modified Guanine Lesions Are Signatures of Chronic Lung Inflammation 
Inflammation is widely documented in common lung diseases, including asthma, chronic obstructive 
pulmonary disease (COPD) and other infiltrative pulmonary diseases [36–41]. In these disease 
conditions, oxidative stress is primarily mediated by ROS generated by activated inflammatory cells, 
which can be enhanced by an increased burden of inhaled environmental agents [42]. ROS, via direct 
signaling or oxidative modification of lipids, proteins and DNA, are believed to play a vital role in 
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maintaining chronic inflammatory processes [2,3,42]. 8-oxoG is one of the most-documented forms of DNA 
base damage in the genome of constituent lung cells [43–50] and lungs of animal disease models [51]. 
Available reports provide strong evidence for the accumulation of 8-oxoG in DNA (and RNA) by 
inflammatory cell(s)—associated ROS, and ROS induced by environmental lung exposures and 8-oxoG 
have been acknowledged as an oxidative bio-marker [43–50]. An etiological connection between 
intrahelical levels of 8-oxoG and inflammatory lung diseases has been proposed; however, it remains 
unknown whether or not these lesions contribute to of inflammatory processes. 
2.3. 8-Oxoguanine DNA Glycosylase-1 (OGG1): Role in Inflammatory Processes 
2.3.1. Lack of 8-oxoG Repair by OGG1 Confers Resistance to Inflammation in Mouse Model 
To study the consequences of 8-oxoG accumulation in DNA and the role of OGG1 in patho-physiological 
processes, Ogg1 knockout (Ogg1−/−) mice were developed in independent laboratories [52,53]. 
Intriguingly, the lack of OGG1 activity and the consequent supraphysiological levels of genomic 8-oxoG 
did not affect mouse embryonic development or life span. Under chronic oxidative stress, 8-oxoG 
levels may increase by 250-fold in Ogg1−/− mice without severe consequences, e.g., the liver regenerated to 
the same extent as it did in untreated Ogg1−/− or Ogg1+/+ mice, and there was no incidence of precancerous 
lesions or tumors in various organs during a 16-month observation period [54,55]. Similarly, although 
high levels of 8-oxoG were found in the mitochondrial DNA (>20-fold increase vs. wild-type), the 
mitochondria were functionally normal, and there were no detectable changes in maximal respiration 
rates or in mitochondrial ROS generation [56]. Unexpectedly, Ogg1−/− mice have shown a decreased 
inflammation upon bacterial infection [57] or challenge with pro-inflammatory agents [58], which may 
mean that these mice lack component(s) of pro-inflammatory signaling, and there is a role for OGG1 
in inflammatory processes. 
Szabo and colleagues documented for the first time that when compared to the wild type, Ogg1−/− 
mice are more resistant to lipopolysaccharide (LPS)-induced inflammation and organ dysfunction [58]. 
The decreased immune response was associated with significantly lower serum chemokine/cytokine 
levels and prolonged survival after LPS exposure, despite a marked increase in LPS-induced oxidative 
stress in the lungs, heart, kidneys, and liver. These authors also documented that Ogg1−/− mice  
are markedly protected from type I diabetes induced by streptozotocin. This protection was obvious from 
decreased hyperglycemia and a low incidence of diabetes, and an increase in β-cell mass. Pancreatic 
levels of macrophage inflammatory protein 1 α (MIP-1α), tumor necrosis factor alpha (TNF-α)  
and interleukin (IL)-12 were significantly lower, while basal pancreatic levels of IL-10 were increased  
in Ogg1−/− mice compared to the wild type (Ogg1+/+) ones [58]. Although these studies did not extend  
to lung tissue, it is noteworthy that patients with chronic lung inflammation have a greater risk of type 1 
and type 2 diabetes and obesity [59–61], and raises the possibility that OGG1 itself and/or OGG1–BER could 
be the link to the innate immune processes associated with these diseases. 
2.3.2. Decreased Allergic Immune Responses in the Lungs of Ogg1 Knockout (Ogg1−/−) Mice 
Li and colleagues [62] documented that, when compared to Ogg1+/+, ovalbumine (OVA) challenge 
of Ogg1−/− mice causes significantly less inflammatory cell infiltration. A decreased inflammatory 
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response was associated with lower levels of T helper (Th) 1 (TNF-α, IFN-γ, IL-2, and IL-12),  
and Th2 cytokines (IL-4, IL-6, and IL-10) and IL-17 levels in BALF and lung tissues. This was,  
in turn, due to decreased signal transducers and activators of transcription-1 (STAT1), STAT3, and STAT6 
expression/signaling, and thereby to decreased NF-κB phosphorylation, after OVA challenge. These results 
are supported by data showing that downregulation of Ogg1 by siRNA led to lower ROS release and  
IL-4, IL-2, and IL-17 production, but higher IFN-γ production in lung epithelial cells [62]. The authors 
concluded that OGG1 may influence airway inflammation via the regulation of oxidative stress (OS). 
Substantial amounts of data support the idea that the airway epithelium is the primary cell type  
in orchestrating an inflammatory response in the lungs [3,63,64]. Therefore, Bacsi and colleagues [65] 
investigated how OGG1-initiated repair of oxidatively damaged DNA in the airway epithelium 
impacts innate and allergic immune responses. To do so, RNAi technology was used to ablate OGG1 
from the airway epithelium of ragweed pollen grain extract (RWPE)-sensitized animals [66–68] 
(OGG1-deficient: OGG1D mice) before inducing allergic lung inflammation by RWPE challenge. 
Mice treated with scrambled RNAi were used as controls (OGG1 proficient: OGG1P mice). In these 
studies, Ogg1−/− mice were avoided, as they lack OGG1 activity globally (i.e., in epithelia, dendritic 
cells, mast cells, macrophages, neutrophils and eosinophils). The results showed that the RWPE 
challenge-induced allergic inflammatory response was significantly lower in sensitized OGG1D mice, 
as determined by the expression of Th2 cytokines, number of eosinophils recruited to airways, 
epithelial metaplasia, and airway hyperresponsiveness (AHR). In contrast, OGG1–BER proficiency  
in the airway epithelium was coupled to robust innate (from 6–24 h) and late allergic (from 48–144 h) 
inflammation. The role of OGG1–BER in these processes was specific, as RNAi depletion of the  
Nei-like glycosylases NEIL1 and NEIL2 that preferentially excise ring-opened purines and 5-hydroxyuracil, 
respectively, had no significant inhibitory effect. In fact, NEIL2 somewhat increased innate and allergic 
immune responses. The mechanism of this is being presently investigated. 
Studies by Bacsi et al. [65] have provided a mechanism as to how OGG1-initiated BER of 8-oxoG 
is involved in exacerbation of antigen-induced allergic inflammatory processes. OGG1 excises 8-oxoG 
and FapyG from DNA with high efficiency [20], and, via its lyase activity, cleaves the DNA backbone, 
transiently generating single-strand gaps [69–71]. Under physiological conditions, these gaps are fully 
repaired in consecutive steps of the BER processes (Figure 1) [20,72]. In response to RWPE challenge, 
an initial robust innate immune response (from 4 h on, as determined by the recruitment of neutrophils) 
was observed in OGG1-proficient but not in OGG1-deficient mice. In parallel with neutrophilia,  
a significant increase was observed in DNA single-strand breaks (DNA SSBs) in the genome of airway 
epithelial cells. The exact mechanism of DNA SSB formation is unknown; however, the authors speculate 
that under neutrophil-generated oxidative stress (OS) conditions, OGG1–BER may not be completed,  
due to an OS-induced imbalance between glycosylase and AP lyase reactions during BER. OS may also 
compromise OGG1’s binding to apurinic/apyrimidinic (AP) sites, and thereby decrease its effects 
protecting DNA ends against oxidative erosion and apurinic/apyrimidinic (AP) site-cleaving enzymes, 
such as endonuclease III-like protein 1 and DNA topoisomerases [69,70,73], leading to SSBs. DNA 
SSBs induced signaling for the activation of transcription factors (e.g., NF-κB), and consequently,  
the increased expression of Th2-type inflammatory chemokines/cytokines [74–80] is well-documented. 
Bacsi and colleagues concluded that the products of OGG1–BER, including DNA repair intermediate(s) 
(AP-sites and/or DNA SSBs)-induced signaling, increased the expression of Th2 cytokines and allergic 
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immune responses upon challenge of sensitized OGG1-proficient mice. In contrast, mice without OGG1 
in their airway epithelium lacked repair of 8-oxoG, so AP-sites and transient DNA SSBs generated  
by OGG1 conferred resistance to allergic immune responses. These results support the idea that  
supra-physiological levels of 8-oxoG in the genomes of airway epithelium may not trigger inflammatory 
processes in mouse model of lung inflammation. 
2.4. OGG1-Initiated DNA Base Excision Repair Pathway (OGG1–BER): A Link to  
Pro-Inflammatory Signaling 
2.4.1. OGG1–BER Results in Activation of Small Guanosine Triphosphatases (GTPases) 
An implication of OGG1–BER in cell signaling was not evident until recent studies, showing that 
OGG1 binds free 8-oxoG base with high affinity, and the formed OGG1·8-oxoG complex has guanine 
nucleotide exchange factor (GEF) activity [81]. The binding constant (Kd) of 0.56 nM indicates tight 
binding of OGG1 with free 8-oxoG base [81]. These results led us to predict that the product’s binding 
would inhibit OGG1’s glycosylase activity, as is the case with most enzymes. However, to our surprise, 
results from additional experiments showed that 8-oxoG stimulated OGG1’s glycosylase activity  
in a concentration-dependent manner [81], which may mean that 8-oxoG serves as a cofactor for OGG1 
by binding to an independent site, and not to the active site pocket in OGG1 as shown previously [21,22]. 
The binding by OGG1 of 8-oxoG base induced conformational changes (as assessed by OGG1’s 
intrinsic tryptophan fluorescence) in a concentration-dependent manner [81]. In contrast, 8-oxoG base 
failed to change tryptophan fluorescence when added to mitochondrial form of OGG1 (OGG1-2a; 
unpublished data). The free FapyG (or 7,8-dihydro-8-oxodeoxyguanosine; 8-oxodG) substrate of 
OGG1 in DNA [82] was not bound by OGG1, thereby indicating specificity of OGG1’s binding  
to an 8-oxoG base [81]. 
These intriguing observations gained high significance because the 8-oxoG-induced conformational 
change in the OGG1 molecule allowed its interaction with and activation of small guanosine 
triphosphatases (GTPases). Specifically, in the presence of 8-oxoG, OGG1 caused replacement of  
GDP for GTP bound to Kirsten rat sarcoma viral oncogene homolog (K-RAS; RAS: rat sarcoma), 
neuroblastoma RAS viral oncogene homolog (N-RAS) and Harvey (H)-RAS. Thus, the OGG1·8-oxoG 
complex functions as a GEF in a manner similar to that of other Ras-activating factors [83,84]. The biological 
significance of these in vitro studies was underlined by those showing that increasing the cellular  
8-oxoG level by adding it to cells or activating OGG1–BER rapidly increased RAS–GTP levels in a cell 
type-specific manner. Activation of RAS led to phosphorylation of the mitogen-activated protein 
kinase (MAPK) kinase (MEK1/2), and extracellular signal-regulated kinase (ERK1/2), and the latter’s 
nuclear translocation [81,85]. 
There is high sequence homology among the RAS and Ras homology (Rho) family of small 
GTPases (RHO) family of GTPases (Ras-related C3 botulinum toxin substrate 1 GTPase (RAC1), 
RAC2 and RAC3), and cell division control protein 42 homolog [86], which led us to examine whether 
the repair of oxidatively damaged DNA by OGG1 and consequent formation of OGG1·8-oxoG 
complex activate the RHO family member RAC1. Hajas and colleagues reported that the OGG1· 
8-oxoG complex physically interacts with guanine nucleotide-free and GDP-bound RAC1 protein. 
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This interaction resulted in rapid GDP→GTP, but not GTP→GDP exchange, indicating that OGG1· 
8-oxoG functions as a prototypic GEF [87]. Luo et al. (2014) provided further insights into the biological 
consequences of OGG1-initiated release of 8-oxoG from DNA [88]. These authors have demonstrated 
that only OGG1-expressing cells display increased activation of RHO-GTPase in oxidatively stressed 
cells. These observations were unexpected, as many small GTPases are redox-sensitive, and ROS have  
an effect similar to that of GEFs in that they modulate guanine nucleotide binding of GTPase, which results  
in an increase in their GTP-bound form [86]. Taken together, these results imply that OGG1–BER  
and consequent OGG1·8-oxoG complex formation lead to activation of canonical RAS and RHO 
family GTPases [81,85,87–89]. These results also imply that the 8-oxoG base generated during  
OGG1–BER may serve as a second messenger, as proposed previously [8]. 
2.4.2. Activation of Rat Sarcoma (RAS) Family GTPases by OGG1–BER Product 8-oxoG in Lungs 
To test for the link between OGG1·8-oxoG and RAS activation, as well as increased pro-inflammatory 
chemokine/cytokine expression and inflammation, mouse lungs were challenged intranasally with  
8-oxoG base (50 ng per kg, as determined in preliminary studies). At various times thereafter, lung 
extracts were prepared and activated levels of RAS–GTPase examined by an active RAS pull-down 
assay. Challenging the lungs with 8-oxoG base resulted in activation of RAS–GTPase as shown  
in Figure 2A (the 45-min time point is shown). OGG1 also excises FapyG [6,90], so we challenged lungs 
with FapyG (50 ng per kg). As shown in Figure 2A, FapyG failed to increase the GTP-bound levels  
of RAS (RAS-GTP). Similarly, the free 8-oxodG (50 ng per kg) failed to activate RAS GTPase, in line 
with its inability to bind OGG1 [81] or activate RAC1 and RHO member A GTPases [87,91,92]. Figure 2B 
shows a time-dependent increase in the percentage of activated RAS–GTP levels in the lungs of individual 
mice as determined by enzyme-linked immunosorbent assay (ELISA). A summary of RAS–GTP levels  
in experimental groups is shown in the inset to Figure 2B. Although RAS activation after exposure  
of cultured cells to 8-oxoG has been documented [81], this is the first detailed analysis of RAS activation  
in the lungs. These results also imply that the 8-oxoG, when installed into airways, penetrated  
the airway lining fluid and was taken up by cells of the airway epithelium in a manner similar to that  
of cultured cells [81,93]. 
Utilizing cultured cells, previous studies showed that activation of RAS by OGG1·8-oxoG induces 
downstream signaling, e.g., MEK1/2, and ERK1/2 [81,85]. To further these observations, the findings 
from microarray analysis of gene expression (accession number: NCBI, GEO #GSE26813) were analyzed 
further by Ingenuity Pathway Analysis software. The results showed that eight of the top 10 pathways  
that responded to 8-oxoG exposure involved the small G protein RAS [81]. These observations are  
in agreement with those showing that RAS–GTPase-induced downstream signaling involves MAPKs 
and phosphoinositide 3-kinase (PI3K) [94,95], and that signals from the RAS GTPases affected many 
major cellular processes, including those driving inflammation in pulmonary diseases [95–99]. 
The relevance of RAS–GTPase and downstream signaling in lung inflammation is underlined  
by studies using pharmacological inhibitors of RAS and RAS-induced pathways. For example, the Ras 
antagonist, farnesylthiosalicylic acid (FTS), was found to be beneficial in lowering autoimmune, acute 
and chronic inflammatory processes [100]. Similarly, the MAPKK kinase (Raf-1) inhibitor GW5074 
and the MEK1,2 inhibitor U0126 both significantly decreased allergic immune responses in a mouse 
Int. J. Mol. Sci. 2014, 15 16983 
 
 
asthma model [101]. The Raf-1 inhibitor GW5074 was effective in preventing smoke-induced AHR  
in mice [102]. PD098059, a MEK1,2 inhibitor, inhibited LPS-induced release of TNF-α and IL-6 from 
both monocytes and lung macrophages [103]. The PI3K inhibitor LY294002 decreased airway eosinophilia, 
mucus hypersecretion, cytokine levels and AHR [101], and also prevented chemokine-induced, sustained 
cell adhesion in vivo [104]. 
Figure 2. Activation of rat sarcoma–small guanosine triphosphatases (RAS–GTPases) in lungs 
by 8-oxo-7,8-dihydroguanine (8-oxoG) challenge. (A) Challenge of airways with 8-oxoG,  
but not 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG) or 7,8-dihydro-8-oxo-2'-
deoxyguanosine (8-oxodG) (50 ng per kg) increased the GTP-bound levels of RAS (RAS–GTP) 
levels. Mice (albino, laboratory-bred strain c; Balb/c) were challenged intranasally (i.n.) for 
45 min, and lung extracts then prepared for active RAS pull-down assays, as we previously 
described [81]. Upper panel: RAS–GTP levels in lung extracts of 3–4 individual mice.  
RAS–GTP was captured by a RAS pull-down assay from 160 μg of lung extract  
and immunoblotted using Pan-RAS antibody (Ab). Lower panel: Abundance of total RAS  
in 20 μg per lane of lung extracts, as shown by pan-RAS Ab. 8-oxoG, 8-oxo-7,8-dihydroguanine; 
FapyG, 2,6-diamino-4-hydroxy-5-formamido-pyrimi-dine; 8-oxodG, 7,8-dihydro-8-oxo-2'-
deoxy-guanosine; (B) Time course of RAS–GTPase activation after 8-oxoG challenge  
of lungs. Individual mice were challenged with 8-oxoG (50 ng mg per kg, dose is determined 
in preliminary studies) i.n. and GTP-bound RAS was determined by ELISA pull-down 
assays [105]. RAS–GTP was captured from 160 μg of lung extract. The percentages  
of increase were calculated using MS Excel. The abundance of total RAS was determined  
in 20 μg of lung extract by ELISA pull-down assays. Animal experiments were performed 
according to the NIH Guide for the Care and Use of Experimental Animals and approved  
by the UTMB IACUC (no. A0807044). 
 
2.4.3. Pro-Inflammatory Gene Expression in the Lungs upon Challenge with 8-oxoG Base 
Increased 8-oxoG levels in the serum, urine, and sputum of individuals exposed to environmental 
pollutants or of asthmatic and COPD patients are considered biomarkers of ongoing inflammatory 
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processes (see above). In vivo, the 8-oxoG base can be generated specifically by OGG1-initiated BER [20]. 
Although proven by fluorescence spectroscopy in vitro [81], we propose that when added to the cells 
8-oxoG is internalized and can form a functional complex with OGG1 in cellulo before being excreted 
from the cells into the extracellular milieu. This hypothesis is supported by data showing that in OGG1 
activity-deficient mice, which do not generate the 8-oxoG base, innate and allergic inflammation  
are decreased after challenge with LPS, OVA, or RWPE [58,62,65]. 
To test the role of OGG1–BER in an immune response, mouse lungs were challenged with the repair 
product, 8-oxoG base, as described in the legend to Figure 2, and changes in mRNA levels were 
determined. In preliminary experiments, mRNA levels of tumor necrosis factor (Tnf) and chemokine 
(C–C motif) ligand 3 (Ccl3) were examined using appropriate primers with qRT-PCR. As shown  
in Figure 3, Ccl3 (encoding the chemokine CCL3, also called macrophage inflammatory protein 1 alpha), 
and Tnf mRNA levels were increased from 30 min on, reaching their maximum after 60–120 min  
of challenge. We also examined their expression at the protein level after 120 min of 8-oxoG exposure. 
We found that protein levels of TNF-α and CCL3 were increased 10,600 and 9200-fold, respectively, 
compared to the mock-treated control. These mediators individually or in combination are potent 
inducers of pro-inflammatory gene expression [36]. Therefore, a more comprehensive analysis of gene 
expression at mRNA levels of pro-inflammatory mediators induced by 8-oxoG challenge was restricted 
to 120 min. 
Figure 3. Expression of inflammatory mediators induced by 8-oxoG base challenge.  
Eight-week-old female Balb/c mice were used for these studies. Mice (n = 5–6) were 
challenged i.n. under mild anesthesia with 60 µL of pH (7.4) balanced saline solution 
containing 50 ng per kg 8-oxoG, or only saline [68]. After 0, 30, 60 and 120 min of exposure, 
lungs were removed, and RNAs were isolated. After reverse transcription, mRNA levels of 
selected cytokines were determined using individual primer pairs. qRT-PCR was performed in 
an ABI7000 Sequencer, and expression levels were calculated by the ΔΔCt method [106,107]. 
Animal experiments were performed as described in the legend to Figure 2. 
 
Next, mice were challenged with 8-oxoG base (50 ng per kg), lungs were harvested, and RNAs 
were isolated after 0, 60 min and 120 of challenge. Purified RNAs from five mice per time point were 
pooled and reverse transcribed, and the cDNAs subjected to analysis. RNA levels of pro-inflammatory 
mediators were determined by using an RT² Profiler PCR Array containing 84 key genes (Mouse 
Inflammatory Cytokines & Receptors PCR, SABiosciences, Valencia, CA, USA). The results  
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are summarized in Figures 4,5 and Table 1. Figure 4 shows changes in RNA levels of C–C motif  
and C–X–C motif chemokines, their receptors, interleukins and cytokines. Unsupervised hierarchical 
clustering divided the 84 genes into two major clusters. Cluster A contained genes having increased 
expression of Ccl1, Ccl19, Ccl2, Il6st, Il4, Il13, Il3 and Igam only at 60 min (1.8–2.1-fold)  
and unaltered, or downregulated (e.g., Cxcl111, Ccl12, Ccl24, Il20, Ifng, Il17b) at all time points. Cluster 
B contains 37 genes out of which 19 genes were upregulated (>2-fold, also shown in Table 1). Genes 
with increased expression include C–C motif (Ccl17, Ccl19, Ccl20, Ccl3, Ccl4, Ccl6, Ccl9), and C–X–C 
motif chemokines (Cxcl1, Cxcl5) and Tnf. In addition to chemokines/cytokines, 8-oxoG challenge of lungs 
increased the expression of chemokine receptors, including Ccr1, Ccr7 and Ccr8. As shown in Table 1, 
Cxcl1 expression is the highest (>65-fold) among the genes included in the array, followed by Ccl3 
(>10-fold), Ccl20 (>7-fold), Tnf (<9-fold), IL1a (>5-fold) and IL1b (>4-fold). We note that mRNA 
levels for these chemokines and cytokines could actually be higher at the site of exposure in the airway 
epithelia, as RNAs were isolated from the whole lungs. 
For further evaluation, genes altered significantly at 60 min post-exposure were subjected  
to PANTHER analysis to identify and rank the signaling pathways [108]. The results from this analysis 
showed that the OGG1–BER product 8-oxoG base induced several pathways, including inflammation 
mediated by chemokines and cytokines (38.9%; Panther (P) # p00031), interleukin (25%, P #p00036), 
and apoptosis signaling (11%, P # p00006). Analysis also showed modulation of Toll receptor (8.3% P 
# p00054), p38 MAPK (5.6% P # p00018), p53 (5.6% P # p00059), and integrin as well as  
wingless-type mouse mammary tumor virus integration site family proteins signaling (2.9%). 
Table 1. Expression of C–C, C–X–C, interleukins (ILs) and TNF in 8-oxoG-challenged lungs. 
Symbol RefSeq ID Name 
60 min 120 min 
Fold Change 
Ccl17 NM_011332 Chemokine (C–C motif) ligand 17 2.25 1.62 
Ccl19 NM_011888 Chemokine (C–C motif) ligand 19 2.28 −1.04 
Ccl20 NM_016960 Chemokine (C–C motif) ligand 20 7.30 5.02 
Ccl3 NM_011337 Chemokine (C–C motif) ligand 3 10.53 10.53 
Ccl4 NM_013652 Chemokine (C–C motif) ligand 4 2.16 1.02 
Ccl6 NM_009139 Chemokine (C–C motif) ligand 6 2.00 1.97 
Ccl9 NM_011338 Chemokine (C–C motif) ligand 9 2.09 2.22 
Ccr1 NM_009912 Chemokine (C–C motif) receptor 1 2.03 1.29 
Ccr7 NM_007719 Chemokine (C–C motif) receptor 7 2.50 2.28 
Ccr8 NM_007720 Chemokine (C–C motif) receptor 8 2.76 2.84 
Cxcl1 NM_008176 Chemokine (C–X–C motif) ligand 1 41.27 65.21 
Cxcl5 NM_009141 Chemokine (C–X–C motif) ligand 5 1.32 2.47 
IL1α NM_010554 Interleukin 1 α 4.09 5.29 
IL1β NM_008361 Interleukin 1 β 4.31 4.40 
IL1r2 NM_010555 Interleukin 1 receptor, type II −1.07 2.01 
IL3 NM_010556 Interleukin 3 2.28 −2.12 
IL4 NM_021283 Interleukin 4 2.10 −2.47 
Itgam NM_008401 Integrin alpha M 2.01 −1.26 
Tnf NM_013693 Tumor necrosis factor 7.90 9.93 
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Importantly, chemokine/cytokine and interleukin signaling pathways account for more than 60% 
(63.9%) of the total genes activated by OGG1–BER product 8-oxoG, which may mean that 8-oxoG 
challenge induced primarily an inflammatory response. 
Figure 4. Changes in pro-inflammatory gene expression induced by 8-oxoG, the product  
of OGG1-BER. Mice were challenged i.n. with 8-oxoG base (50 ng per kg), and RNA  
was extracted. Total RNA (pooled from five mice) was reverse-transcribed into cDNA  
and analyzed using a Mouse Inflammatory Cytokines & Receptors PCR Array  
(Cat # PAMM-011A, SABiosciences, Valencia, CA, USA). Data were analyzed using RT2 
profiler PCR data analysis template version 2.0. Heat maps were created and unsupervised 
hierarchical clusters were constructed using GENE-E online software (Broad Institute; 
Cambridge, MA, USA). Genes were clustered using Spearman’s rank correlation 
coefficient [108]. The colors in the heat-map show the minimum and maximum values (±3). 
Animal experiments were performed as described in the legend to Figure 2. 
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Figure 5. Signaling pathways induced by exposing the lungs to 8-oxoG base. Analysis  
by PANTHER software included genes that were upregulated in Cluster A and B (Figure 4). 
The percentages of genes for each category were calculated as described previously [108]. 
 
To test whether increased expression of chemokines/cytokines/interleukins translated into actual lung 
inflammation, mice were challenged i.n. with 8-oxoG base (50 ng per kg) [68]. In controls, mice were 
challenged with TNF-α (20 ng per lung, positive control), 8-oxodG (50 ng per kg), or saline. After 16 h 
of challenge, lungs were lavaged, and the numbers of inflammatory cells in BALFs were assessed.  
As shown in Figure 6, 8-oxoG base challenge induced the recruitment of neutrophils into airways. Although 
the doses of TNF-α and 8-oxoG used for challenge may not be comparable, there were no significant 
differences between the number of neutrophils recruited by TNF-α [109] and 8-oxoG base challenge.  
In the lungs of 8-oxodG-challenged mice, there were only background levels of neutrophils. 
Figure 6. The OGG1–BER product 8-oxoG induces neutrophil recruitment to the lungs.  
Mice (n = 5–6) were challenged i.n. with 60 µL of pH-balanced 8-oxoG solution (pH: 7.4; 
50 ng per kg). TNF-α (20 ng per lung) and 8-oxodG (50 ng per kg) and solvent (saline) 
were used as controls. Bronchoalveolar lavage fluid was collected after 16 h of challenge, 
cells on cytospin slides were stained with Wright-Giemsa, and the number of neutrophils 
was counted, as we previously described [68]. All animal experiments were performed  
as described in Figure 2. *** p < 0.001. TNF-α, tumor necrosis factor–α; 8-oxoG,  
8-oxo-7,8-dihydroguanine; 8-oxodG, 7,8-dihydro-8-oxo-2'-deoxyguanosine. 
 
These results suggested to us that the 8-oxoG base was taken up by the epithelium. When internalized, 
8-oxoG possibly formed a complex with OGG1 as proposed previously [81]. The OGG1·8-oxoG 
complex then serves as a guanine nucleotide exchange factor to mediate GDP→GTP exchange. 
Activated RAS GTPases induce downstream signaling pathways leading to chemokine/cytokine/IL 
expression, and consequently an innate inflammatory response. ROS-induced guanine oxidation to 8-oxoG 
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and the repair of this mutagenic base lesion by OGG1–BER are among the first events upon exposure 
to environmental agent(s). Thus, it is reasonable to propose that OGG1–BER could be an interface 
between the environment and cell activation signaling for pro-inflammatory gene expression (Figure 7). 
Although further studies are required, it is proposed that OGG1·8-oxoG→RAS signaling resulting  
in the expression of inflammatory mediators such as CCL17, CCL19, CCL20, CCL3, CCL4, CCL6  
or CCL9 and interleukins could modulate eosinophils, basophils, mast cells, and T and B cell 
function(s) and thus may also affect the adaptive immune system (Th2, regulatory T, or Th17 cells). 
Intriguing previous studies [91,92] showed that 8-oxodG suppressed allergy-associated immune 
responses and tissue remodeling in a mouse model. Another study documented that 8-oxoGTP 
antagonized the superoxide anion generation of human neutrophils. The exact mechanism by which  
8-oxodG or 8-oxoGTP suppresses inflammatory response and inhibit structural changes in lungs as well as 
neutrophil’s respiratory burst is not known. It is possible that both 8-oxodG and 8-oxoGTP are bound  
by OGG1 and form such a complex that inhibits GDP→GTP exchange and thus may counteract the  
pro-inflammatory effects of 8-oxoG.  
Figure 7. A proposed model for lung inflammation by repair of oxidatively damaged DNA 
via OGG1–BER. When environmental exposures occur or during an inflammatory process, 
Reactive oxygen species (ROS) are generated by cellular oxido-reductases and mitochondrial 
dysfunction in the airway epithelium. Due to guanine’s lowest oxidation potential, the most 
frequent base damage in DNA is 8-oxoG, which needs to be repaired to prevent mutations. 
8-OxoG base is released by OGG1–BER (Figure 1) and transported to the cytoplasm, where it is 
bound by OGG1, and the resulting complex (OGG1·8-oxoG) functions as a guanine nucleotide 
exchange factor and mediates GDP→GTP exchange. Activated small GTPase(s) signal 
expression of pro-inflammatory genes, which induce an innate immune response. Recruited 
inflammatory cells induced ROS, DNA damage and repair that may lead to a vicious cycle  
of OGG1·8-oxoG→RAS–GTP→inflammatory signaling, maintaining chronic inflammation. 
 




Environmental exposures and an increase in the genomic 8-oxoG level have been associated with 
inflammatory lung diseases. Intriguing recent studies have shown that a decrease in OGG1 activity 
markedly prevented chemokine/cytokine expression and a cellular inflammatory response. Based on 
previous studies and the data shown in this paper, it is evident that OGG1-initiated DNA BER  
led to the generation of an OGG1•8-oxoG complex that functions as a guanine nucleotide exchange 
factor “fueling” the activation of small GTPases, which generate cell activation signals for increased 
expression of pro-inflammatory chemokines/cytokines leading a full-blown inflammatory response. 
OGG1–BER-mediated inflammation could be an important physiological (beneficial) response aimed 
at host protection upon environmental challenge. However, it is also possible that when the challenge 
of the host occurs in association with pre-existing conditions (e.g., immune-suppression, allergy, age 
or genetic background) where inflammation is not properly controlled, OGG1–BER-driven innate 
signaling may exacerbate ongoing diseases and aging processes. In addition, the data provided in this 
review point to a novel mechanism—the potential role of OGG1–BER in the maintenance of chronic 
inflammation, not only in the lungs, but also in other systemic diseases—such as cardiovascular, 
arthritis, cancer, dementia, obesity, and diabetes. 
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